Jilek Samantha, Walter Elke, Merkle Hans P, Corthésy Blaise
Department of Chemistry and Applied BioSciences, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.
J Allergy Clin Immunol. 2004 Oct;114(4):943-50. doi: 10.1016/j.jaci.2004.05.065.
Biodegradable poly(lactide- co -glycolide) (PLGA) microspheres are a promising carrier for vaccine delivery capable of maturing antigen-presenting cells to stimulate T-cell-mediated immune responses. However, the potential of microspheres to downregulate an allergic response in vivo is unknown.
The aim of this study was to determine whether microspheres could potentiate DNA vaccination against allergy and to evaluate the immunomodulatory properties of microspheres alone.
Mice were treated prophylactically with DNA-loaded plain PLGA microspheres before sensitization with phospholipase A2 (PLA2), the major allergen of bee venom. PLA2-specific IgG1, IgG2a, IgE in serum were measured for 8.5 months, and splenocyte proliferative responses and cytokine profiles were determined. Protection against anaphylaxis was evaluated after injection of an otherwise lethal dose of PLA2.
Phospholipase A2-specific IgG1 and IgG2a production turned out to be 2 times higher using cationic microspheres compared with anionic microspheres, but was not influenced by the presence of DNA. In contrast, reduction in IgE production and T-cell hyporesponsiveness were observed with all microsphere formulations. Recall challenge with PLA2 triggered combined expression of both IL-4 and IFN-gamma, together with sustained expression of IL-10 that can explain the protective effect against anaphylaxis.
Our data suggest a dual mechanism that does initially rely on a TH2 to TH1 immune deviation and then on IL-10-mediated suppression. This is the first physiological demonstration that plain PLGA microspheres can induce tolerance in mice for as long as 6 months postsensitization.
可生物降解的聚(丙交酯-共-乙交酯)(PLGA)微球是一种很有前景的疫苗递送载体,能够使抗原呈递细胞成熟以刺激T细胞介导的免疫反应。然而,微球在体内下调过敏反应的潜力尚不清楚。
本研究旨在确定微球是否能增强针对过敏的DNA疫苗接种,并评估微球单独的免疫调节特性。
在用蜂毒的主要过敏原磷脂酶A2(PLA2)致敏之前,用负载DNA的普通PLGA微球对小鼠进行预防性治疗。在8.5个月内测量血清中PLA2特异性IgG1、IgG2a、IgE,并测定脾细胞增殖反应和细胞因子谱。在注射致死剂量的PLA2后评估对过敏反应的保护作用。
结果表明,与阴离子微球相比,使用阳离子微球时磷脂酶A2特异性IgG1和IgG2a的产生高出2倍,但不受DNA存在的影响。相反,在所有微球制剂中均观察到IgE产生减少和T细胞低反应性。用PLA2进行再次激发引发了IL-4和IFN-γ的联合表达,以及IL-10的持续表达,这可以解释对过敏反应的保护作用。
我们的数据表明存在一种双重机制,最初依赖于TH2向TH1的免疫偏离,然后依赖于IL-10介导的抑制。这是首次生理学证明普通PLGA微球在致敏后长达6个月内可诱导小鼠产生耐受性。